DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
163.32
+1.92 (1.19%)
Nov 21, 2024, 11:04 AM EST - Market open
DaVita Employees
DaVita had 70,000 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
70,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$180,952
Profits / Employee
$11,824
Market Cap
13.39B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 70,000 | 0 | - |
Dec 31, 2022 | 70,000 | 1,000 | 1.45% |
Dec 31, 2021 | 69,000 | 2,000 | 2.99% |
Dec 31, 2020 | 67,000 | 2,000 | 3.08% |
Dec 31, 2019 | 65,000 | -12,700 | -16.34% |
Dec 31, 2018 | 77,700 | 3,200 | 4.30% |
Dec 31, 2017 | 74,500 | 4,200 | 5.97% |
Dec 31, 2016 | 70,300 | 9,900 | 16.39% |
Dec 31, 2015 | 60,400 | 2,500 | 4.32% |
Dec 31, 2014 | 57,900 | 500 | 0.87% |
Dec 31, 2013 | 57,400 | 4,000 | 7.49% |
Dec 31, 2012 | 53,400 | 12,400 | 30.24% |
Dec 31, 2011 | 41,000 | 4,500 | 12.33% |
Dec 31, 2010 | 36,500 | 2,500 | 7.35% |
Dec 31, 2009 | 34,000 | 1,500 | 4.62% |
Dec 31, 2008 | 32,500 | 1,500 | 4.84% |
Dec 31, 2007 | 31,000 | 2,100 | 7.27% |
Dec 31, 2006 | 28,900 | 900 | 3.21% |
Dec 31, 2005 | 28,000 | 12,700 | 83.01% |
Dec 31, 2004 | 15,300 | 1,500 | 10.87% |
Dec 31, 2003 | 13,800 | 800 | 6.15% |
Dec 31, 2002 | 13,000 | 300 | 2.36% |
Dec 31, 2001 | 12,700 | 500 | 4.10% |
Dec 31, 2000 | 12,200 | -100 | -0.81% |
Dec 31, 1999 | 12,300 | 0 | - |
Dec 31, 1998 | 12,300 | 3,470 | 39.30% |
Dec 31, 1997 | 8,830 | 5,705 | 182.56% |
Dec 31, 1996 | 3,125 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fresenius Medical Care AG | 119,845 |
Universal Health Services | 96,700 |
Dr. Reddy's Laboratories | 27,048 |
Solventum | 20,098 |
Revvity | 11,500 |
Globus Medical | 5,000 |
BioMarin Pharmaceutical | 3,401 |
Genmab | 2,204 |
DVA News
- 6 days ago - DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation - Seeking Alpha
- 9 days ago - DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health - PRNewsWire
- 12 days ago - DaVita Inc. to Participate in UBS Global Healthcare Conference 2024 - PRNewsWire
- 22 days ago - DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 22 days ago - DaVita misses third-quarter profit estimates on higher costs - Reuters
- 22 days ago - DaVita Inc. 3rd Quarter 2024 Results - PRNewsWire
- 24 days ago - DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program - PRNewsWire
- 4 weeks ago - DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024 - PRNewsWire